Acquired haemophilia in recipients of depot thioxanthenes.
We present two cases in which the occurrence of acquired haemophilia is associated with the use of depot preparations of the thioxanthenes zuclopenthixol and flupenthixol. These drugs have not previously been implicated in the aetiology of acquired haemophilia.
Stewart
A J
AJ
Haemophilia and Thrombosis Centre, Royal Infirmary of Edinburgh, Edinburgh, UK.
Manson
L M
LM
Dasani
H
H
Beddall
A
A
Collins
P
P
Shima
M
M
Ludlam
C A
CA
D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001323:Autoantibodies / Q000276:immunology; D003006:Clopenthixol / Q000009:adverse effects*; D005169:Factor VIII / Q000276:immunology; D005260:Female; D005475:Flupenthixol / Q000009:adverse effects*; D006467:Hemophilia A / Q000209:etiology* / Q000276:immunology; D006801:Humans
D014150:Antipsychotic Agents; D001323:Autoantibodies; D005169:Factor VIII; D003006:Clopenthixol; D005475:Flupenthixol